Mer­ck wins break­through ther­a­py des­ig­na­tion for po­ten­tial pneu­mo­coc­cal vac­cine suc­ces­sor

Less than a year af­ter win­ning FDA ap­proval for its next-gen­er­a­tion pneu­mo­coc­cal vac­cine last Ju­ly, Mer­ck is al­ready im­press­ing the agency with a po­ten­tial fol­low …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER